Abstract:Dr. G.E. Piérard, Department of Dermatopathology, CHU Sart-Tilman, B-4000 Liège (Belgium) The unprecedented size of the elderly population com Chronologic ageing Genetic ageing Photoageing Behavioral ageing Catabolic ageing, Type Endocrine ageing Gravitational aseins pels research to understand the physiological changes related to skin ageing. A classical, yet oversimplified classification of cutaneous alterations contrasts intrinsic ageing and photoageing. That dual classification does not precisely describe the wide diversity of factors influencing skin ageing. In such a perspective, seven distinct types of factors should be considered (table 1) [1]. In this framework, cutaneous climacteric ageing enters the spectrum of endocrine ageing. Over the past years, hormonal involvement in the ageing process of many tissues and organs has attracted increased interest. Molecular biology and biometrology have helped to sort through some unresolved questions. As a result, a fair amount is known about the basic science involved in estrogen functions. Hormone replacement therapy (HRT) is aimed at alleviating menopausal symptoms and is indicated for the prevention of long-term sequelae of estrogen deficiency. The preventive benefits include a substantial reduction in osteoporosis risk and, possibly, a reduction in the risk of coronary heart disease. Unfortunately, the picture that emerges from skin biology is odd and the influence of estrogen changes on cutaneous structures and functions remains largely unsubstantiated. The open study by Callens et al. [2] in this issue of the Journal is an additional attempt at analytic quantification of subclinical skin changes related to climacteric ageing and HRT. Before analyzing the data, one should remember the potential limitations of such a cross-sectional study design. The causal relationship between measures, estrogen deprivation and HRT cannot be determined with certainty because the characteristics of the women’s skin when they faced the decision regarding HRT are unknown. Subjects who are more likely to use HRT most probably belong to sociodemographic groups different from most untreated postmenopausal women [3]. Hence, the other factors influencing skin ageing may also differ between the two groups and introduce a bias to the study. That human skin changes dramatically with increasing age is patently obvious. However, climacteric ageing lacks unique and distinctive features. The manifestations such as xerosis and atrophy reflect structural changes in both the epidermis and dermis. Integumental reactivity also apparently changes at the time of the menopause, and there is reason to believe that the skin might then become more vulnerable to environmental insults [4-6]. At this point, one enters into a speculative realm, the effect of climacteric ageing being more subtle than has been expected.

Wound dressing after skin planing.

The N‐myc downstream regulated gene (NDRG) family: diverse functions, multiple applications

Prescription Practices in the Treatment of Agitation in Newly Hospitalized Chinese Schizophrenia Patients: Data from a Non-Interventional Naturalistic Study

The quandary of climacteric skin ageing.

Dexmedetomidine Sublingual Film: A New Treatment to Reduce Agitation in Schizophrenia and Bipolar Disorders

Feasibility and Safety of Oral Risperidone to Treat Prehospital Agitation

Ziprasidone, Haloperidol and Clonazepam Intramuscular Administration in the Treatment of Agitation Symptoms in Chinese Patients with Schizophrenia: A Network Meta-Analysis

Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change

Central anticholinergic syndrome from hyoscine hydrobromide in an unresponsive patient

The Safety and Efficacy of Sequential Intramuscular/oral Ziprasidone Treatment of Acute Episode in Patients with Schizophrenia: a Multicenter, Open-Labeled Study

As-needed dosing of antipsychotic drugs: limitations and guidelines for use in the elderly agitated patient

Sublingual apomorphine in the treatment of Parkinson's disease

Long-term sustained release Poly(lactic-co-glycolic acid) microspheres of asenapine maleate with improved bioavailability for chronic neuropsychiatric diseases

Short-term chloral hydrate as an add-on treatment may improve sleep and alleviate agitation in inpatients with treatment resistant schizophrenia: a retrospective case series study

Exploring peptide dendrimers for intestinal lymphatic targeting: formulation and evaluation of peptide dendrimer conjugated liposomes for enhancing the oral bioavailability of Asenapine maleate

Citalopram for agitation in Alzheimer's disease: design and methods

[Determination of residues of chlorinated hydrocarbon pesticides in samples of cultivated soil in Poland].

Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease

Subcutaneous sodium valproate in palliative care: A systematic review

Intramuscular Ziprasidone Versus Haloperidol for Managing Agitation in Chinese Patients with Schizophrenia

Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson’s disease complicated by OFF episodes: a phase 3, open-label study